Here is our Top Docs 2025 profile on Jeffrey Zonder, M.D., who is part of the Karmanos Cancer Institute’s Multiple Myeloma and Amyloidosis Multidisciplinary Team.
The health risks from toxic exposures at Ground Zero of the 9/11 World Trade Center attacks are well documented, and diseases ...
A CRISPR-Cas9-based therapy targeting the gene encoding transthyretin greatly reduced transthyretin levels in patients with ...
DelveInsight's Hereditary Transthyretin Amyloidosis Market Insights report includes a comprehensive understanding of current ...
New research shows that building heart-healthy habits during young adulthood (and earlier) may determine your risk of heart ...
Watercolour prints of local doors, painted by late Frome stalwart John Birkett-Smith, are being exhibited and sold in his ...
Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will present a NXC-201 abstract at the upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback